Board summary
Key figures
30,205
Registered population
59.0% aged 18–64
19.8%
Aged 65+
ICB 18.8% · England 17.9%
25.8%
Ethnic minority (non-White)
20.1% Asian · England 9.6%
0.6%
In IMD quintile 1
ICB 0.8% · England 21.0%
~107
Core20 residents (est.)
Resident basis; registered basis ~127 · see page 3
4,389
Hypertension register
+5.75% in 3 yrs · England +5.60%
197
SMI register
19.6% of Woking's
357
COPD register
Reviews -0.37% in 3 yrs
Forecast to 2030
4,996
Hypertension patients, 2030
+607 on today
78.8%
QRISK ≥20% on statins, 2030
+6.26pp over 3 yrs
5.4%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Heart failure and respiratory review trends lag England.
Three-year changes trail England for heart failure (-7.2% vs +8.7%) and asthma reviews (-0.1% vs +4.4%; 562 unreviewed), which may reflect unverified recall capacity.
Vaccination achievement and phone access vary across practices.
QOF vaccination spans 72.3 pp (21.4% at The Practice College Road; 93.7% at St John's Family Practice), while easy phone contact spans 44.9 pp.
Hypertension control and lipid therapy exceed England averages.
Hypertension treated to target reaches 77.2% (England 70.3%; 3-year change +6.4% vs +3.6%), alongside 64.2% lipid therapy for QRISK ≥ 20% (England 63.6%).
Population, age and ethnicity
Registered patients aged 65+ reach 19.8% alongside a 20.1% Asian resident share
Across 30,205 registered patients in four practices (ranging from 3,873 at The Practice College Road to 11,152 at St John's Family Practice), 19.8% (5,984) are aged 65+, exceeding Woking (15.3%), NHS Surrey Heartlands ICB (18.8%), and England (17.9%). Patients aged 0-17 comprise 21.2% (6,410). Based on Census usual residents rather than registered patients, 20.1% are Asian or Asian British—above Woking (14.2%), the ICB (7.7%), and England (9.6%)—concentrated at The Practice College Road (28.4%) versus Chobham & West End Medical Practice (4.9%). This older profile and ethnic diversity may shape chronic disease capacity and outreach, though unverified locally.
Age profile
65+: ICB 18.8%, England 17.9%
Ethnicity
Older people · falls rows are Woking local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Woking LA) | 1,854 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 85.0% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 64.2% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Woking LA) | 796 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Woking LA) | 11.2 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
PCN Core20 share is 0.6%, concentrated at The Practice College Road at 3.3%
WOKING WISE 1 PCN averages IMD decile 8.0, compared with 7.8 in Woking, 7.9 in NHS Surrey Heartlands ICB, and 5.5 in England. Overall Core20 prevalence is 0.6%, below England (21.0%), Woking (1.5%), and the ICB (0.8%). Core20 patients concentrate entirely at The Practice College Road (3.3%, 127 estimated patients), with 0.0% across Chobham & West End Medical Practice, Pirbright Surgery, and St John's Family Practice. Weighted practice share (0.4%) differs from the PCN rate by 0.19 percentage points, while resident decile 1 and 2 estimates total 107.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
197
SMI register
0.64% recorded prevalence
123
Learning disability register
0.40% recorded prevalence
15
Care homes, 591 beds
In the PCN catchment
8.3%
Provide unpaid care
Woking, Census 2021
Recorded learning disability prevalence (0.4%, 123 patients) and severe mental illness (0.6%, 197 patients) trail Woking (0.5%; 0.8%), the ICB (0.5%; 0.8%), and England (0.6%; 1.0%). Catchment care homes provide 15 sites (591 beds). At borough level, Woking has an 8.3% unpaid care rate and recorded 6 rough sleepers in 2025. Clinical register audits would test whether lower recorded prevalence reflects demographic differences or unrecorded need.
Severe mental illness: physical health checks
SMI prevalence is 0.6% (197 patients; England 1.0%). Physical checks show 85.8% had blood pressure recorded and 82.6% BMI (England 83.4% and 82.1%), but alcohol status was 78.1% (England 81.8%), suggesting scope to complete full health checks.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
4,389
Hypertension register
+5.75%
Register growth, 3 yrs
Woking +6.51% · England +5.60%
+4.36pp
BP control, under 80
≤140/90 · +2.51pp aged 80+
+607
More patients by 2030
Forecast 4,996 (16.03%)
Hypertension case-finding and control
Recorded hypertension prevalence is 14.3% (4,389 patients), above Woking (13.2%), matching NHS Surrey Heartlands Integrated Care Board (14.3%), and below England (15.2%), with an unadjusted benchmark gap range of -396 to +211 patients. Clinical control is high: 91.4% have a recent blood pressure reading (England 90.0%), and 77.2% are treated to target (England 70.3%), including 72.7% under age 80 (England 67.8%) and 89.1% aged 80 and over (England 81.2%). Over three years, patients treated to target rose +6.4% (England +3.6%). Although clinical control is strong, recorded prevalence below England indicates an opportunity to review opportunistic screening.
Lipids and statins
At 64.2%, patients with QRISK ≥ 20% receiving lipid-lowering therapy exceed England (63.6%), Woking (61.7%), and NHS Surrey Heartlands Integrated Care Board (59.4%), after a 3-year rise of +10.8% (England +6.2%). Treatment rates above all benchmarks show effective cardiovascular primary prevention to sustain.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 34,567 | £2.20 | £2.24 | £1.86 | £76,047 |
| Cardiovascular (all), 2025 | 44,666 | £4.57 | £4.74 | £3.33 | £204,124 |
In 2026, 34,567 lipid-regulating items averaged £2.20 each (England £1.86, NHS Surrey Heartlands Integrated Care Board £2.24, Woking £2.50). This was £11,753 more than at England's unit cost, but £1,383 less than at NHS Surrey Heartlands Integrated Care Board unit cost. Higher unit spend than England indicates a potential formulary review opportunity.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
−0.06%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+6.26%
Asthma prevalence, PCN 3-yr % change
The asthma register includes 1,738 patients (6.0% prevalence, England 6.6%), having grown +6.3% over three years (England +0.5%). Annual asthma reviews reached 67.7% (England 65.7%, Woking 68.1%), but three-year review change was -0.1% (England +4.4%), leaving 562 patients unreviewed as a scale indicator. COPD prevalence is 1.2% (357 patients; England 1.9%), with reviews at 81.5% (England 76.4%) despite a three-year change of -0.4% (England +2.8%). Stagnating review trends across growing registers suggest routine recall capacity may be constrained.
Cancer register and children's immunisation
The cancer register has 1,372 patients (4.5% prevalence, England 3.8%). Childhood immunisations achieve 94.9% for 6-in-1 at 12 months (England 91.0%), but coverage drops by age five: MMR dose 2 reaches 83.8% (below the 95.0% target by 11.2 pp; England 82.8%) and the 4-in-1 booster reaches 79.4% (below target by 15.6 pp; England 80.9%). Within the age-five cohort, MMR dose 2 trails MMR dose 1 (91.2%) by 7.4 pp.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
61.4%
Surrey Heartlands ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~650
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Surrey Heartlands ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Prostate | 65.7% | 53.2% | 18% | 1,044 |
| Breast | 88.2% | 85.4% | 27% | 798 |
| Bowel | 48.1% | 47.0% | 18% | 626 |
| Lung | 33.2% | 33.8% | 17% | 497 |
| Skin cancer | 89.8% | 87.8% | 19% | 384 |
In NHS Surrey Heartlands ICB, 61.4% of cancers with a known stage (2,955 of 4,810) were diagnosed at stage 1 or 2 in 2022, above England (55.3%) but 13.6 pp below the 75.0% national ambition by 2028 (about 650 extra cases needed). Known stage was recorded for 67.7% of registered cancers. Across WOKING WISE 1 PCN, cancer prevalence is 4.5% (1,372 patients), with a 3-year change of +9.9% (England +9.0%). Cervical screening (aged 25 to 49) reached 68.3% (England 66.8%), with a 3-year change of -2.6% (England -1.0%), while The Practice College Road recorded 47.5%. Declining screening uptake may delay early detection, warranting targeted recall at lower-uptake practices.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In July 2026, provider Ashford and St Peter's Hospitals NHS Foundation Trust achieved 85.5% on the 28-day faster diagnosis standard (standard 75.0%), exceeding England (79.3%) and Royal Surrey NHS Foundation Trust (82.6%). On the 62-day standard, it reached 76.4% (standard 85.0%), trailing Royal Surrey NHS Foundation Trust (84.5%). For diagnostics, 49.6% of colonoscopy and 57.9% of flexi sigmoidoscopy patients waited 6+ weeks (England 30.8% and 32.1%; Royal Surrey NHS Foundation Trust 0.0% each). These provider figures describe system activity rather than PCN cohorts. Endoscopy delays at the provider could affect diagnostic resolution for lower gastrointestinal referrals.
| Pathways within standard (%) | Ashford and St Peter's | Royal Surrey | Frimley Health | Surrey and Sussex ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 85.53 | 82.62 | 87.95 | 79.29 | 79.32 |
| 31-day treatment (96%) | 94.21 | 96.43 | 92.89 | 90.45 | 92.50 |
| 62-day referral to treatment (85%) | 76.38 | 84.48 | 81.84 | 71.51 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Ashford and St Peter's | Royal Surrey | Frimley Health | England |
|---|---|---|---|---|
| MRI | 0.09 | 0.00 | 12.85 | 21.40 |
| CT | 9.27 | 0.15 | 0.63 | 9.92 |
| Echocardiography | 0.97 | 1.55 | 3.35 | 28.48 |
| Colonoscopy | 49.61 | 0.00 | 22.84 | 30.83 |
| Gastroscopy | 56.74 | 0.00 | 7.43 | 29.02 |
| All 15 DM01 tests | 23.12 | 8.82 | 7.49 | 23.14 |
| Community services activity | Surrey residents | Surrey and Sussex ICB |
|---|---|---|
| Care contacts | 109,530 | 309,615 |
| Referrals | 28,700 | 66,930 |
| Patients with a contact | 33,510 | 85,660 |
Community services (residents of Surrey), Jun 2026 (provisional). In June 2026, community services recorded 109,530 contacts for Woking borough residents, with 76,215 involving adults aged 65+ (69.6% of all contacts). While these figures capture borough residents rather than PCN-registered patients, they reflect community healthcare use among older residents. Community contact volumes among older residents suggest scope to align PCN proactive reviews with local community teams.
Practice variation and patient experience
Easy phone access spans 44.9 percentage points and vaccination achievement spans 72.3 percentage points
Overall QOF achievement spans from 78.2% at Chobham & West End Medical Practice to 99.3% at St John's Family Practice (England 92.5%). Vaccination and immunisation achievement varies by 72.3 pp, from 21.4% at The Practice College Road to 93.7% at St John's Family Practice (England 55.2%). QOF points reflect incentive thresholds rather than unique patient coverage.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Pirbright Surgery | 106 | 0.0 | 83.2% | 73.7% | 89.0% |
| College Road | 96 | 3.3 | 76.9% | 83.5% | 82.4% |
| St John's | 125 | 0.0 | 45.2% | 78.3% | 74.1% |
| Chobham & West | 109 | 0.0 | 38.3% | 73.6% | 48.4% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Heart failure reviews fell 7.2% over three years while lipid therapy grew 10.8%
Five indicators trail national three-year trends, led by heart failure reviews falling 7.2% (Woking +15.8%, England +8.7%), asthma reviews falling 0.1% (England +4.4%), COPD reviews falling 0.4% (England +2.8%), cervical screening declining 2.6% (England -1.0%), and hypertension blood pressure checks rising 2.6% (England +3.6%). In contrast, gains include severe mental illness alcohol checks rising 12.2 pp (England +5.4 pp), QRISK ≥ 20% lipid therapy rising 10.8% (England +6.2%), and diabetes statin therapy rising 5.8% (England +2.1%). Trailing review rates may reflect recall capacity constraints, which an audit of practice recall processes would test.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Heart failure reviews
Asthma reviews
COPD reviews
Cervical screening
Hypertension BP reading
Alcohol record (psychosis)
QRISK statin treatment
Diabetes statin (no CVD)
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Woking | Asset | PCN | Woking |
|---|---|---|---|---|---|
| Care homes (catchment) | 15 (591 beds) | n/a | Schools (catchment) | 69 | n/a |
| Children's centres | 6 | 8 | Places of worship | 32 | 49 |
| Libraries | n/a | 1 | Homelessness support (VCS) | 0 | no data |
| Day centres (VCS) | 2 | 2 | Carers support groups (VCS) | 1 | 1 |
| Primary schools (LA maintained) | 2 | 2 | Primary academies | 18 | 19 |
| Special schools | n/a | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Respiratory annual review recall and case-finding
Asthma reviews reached 67.7% (England 65.7%) after a -0.1% 3-year change (England +4.4%), leaving 562 of 1,738 patients unreviewed; COPD prevalence is 1.2% (357 patients vs England 1.9%, gap -2 to +215). Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Hypertension case-finding and Core20 outreach
Hypertension prevalence is 14.3% (4,389 patients), above Woking (13.2%) and matching the ICB (14.3%) but below England (15.2%), giving an unadjusted gap range of -396 to +211 patients. For discussion, the PCN could search for patients with uncoded raised blood pressure readings and offer opportunistic checks where Core20 patients concentrate. Low cost, quick to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Option 3
Learning disability and heart failure validation
Learning disability prevalence is 0.4% (123 patients vs England 0.6%; gap +26 to +55), while heart failure prevalence is 0.9% (281 patients vs England 1.1%; gap -4 to +51) and 3-year reviews fell 7.2% (England +8.7%). Low cost, quick to run.
Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.
Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Culturally tailored outreach and communication (p2) | Asian / Asian British | Neighbourhood health framework · Core20PLUS5 approach | PCN |
| Targeted Core20 outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| Psychosis alcohol status review (p4) | Patients with psychosis who have a current record of alcohol consumption | MHIS · From Harm to Hope | PCN |
| Opportunistic blood pressure screening review (p5) | Hypertension: QOF prevalence | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Preschool booster recall review (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall outreach (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Practice phone access review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Respiratory annual review recall and case-finding (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD register | Core20PLUS5 respiratory | PCN |
| Option 2 · Hypertension case-finding and Core20 outreach (p12) | Hypertension register · Hypertension: QOF prevalence · Asian / Asian British | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN & Practice |
| Option 3 · Learning disability and heart failure validation (p12) | Learning disability register · Learning disability: QOF prevalence · Heart failure register | 75% annual health checks (Network Contract DES) · Oliver McGowan | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
